🔴 We are now live with an inspiring presentation by Dr. Leonora Balaj, PhD, Assistant Professor of Neurosurgery at Harvard Medical School and Massachusetts General Hospital, USA, exploring how liquid biopsy is transforming the diagnosis and management of brain tumors.
Presentation: Messages in the Blood: Liquid Biopsy Insights for Brain Tumors
Brain tumors present unique diagnostic challenges due to the difficulty of safely accessing tumor tissue and monitoring disease progression over time. In this session, Dr. Balaj is demonstrating how liquid biopsy is providing a powerful, minimally invasive approach to uncovering critical molecular information through blood-based biomarkers.
Drawing on her pioneering research in extracellular vesicles, circulating biomarkers, and neuro-oncology, Dr. Balaj highlights how tumor-derived signals in blood and other biofluids can reveal valuable insights into tumor biology, disease progression, treatment response, and molecular evolution.
The presentation also explores the latest advances in detecting and interpreting circulating biomarkers, illustrating how these technologies are bringing precision medicine closer to patients with brain tumors while supporting more personalized and timely clinical decision-making.
This engaging session showcases the growing impact of liquid biopsy in neuro-oncology and its potential to reshape the future of brain tumor diagnosis, monitoring, and personalized care.
We extend our sincere thanks to Dr. Leonora Balaj for sharing her expertise and to our global audience for participating in today’s scientific discussions.
This conference is organized by Impact Research Communications (IRC)
More info: https://liquidbio.ircconferences.net/ | Advances in Liquid Biopsy
